Francisco, Lyka D.
HRN: 22-45-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
05/26/2023
06/02/2023
IVTT
600mg As LD Then 300mg As MD
Q24
Candidiasis
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes